ap

Skip to content
PUBLISHED:
Getting your player ready...

New York – A new, large study suggests that treating women who develop diabetes during pregnancy greatly reduces the chances that their babies will become obese during childhood.

The research found that the higher the mother’s blood sugar levels, the greater the child’s risk of being obese by age 5 to 7, even if the mother wasn’t diagnosed with diabetes.

Untreated high blood sugar nearly doubled the child’s risk of becoming overweight or obese, said the study’s lead author, Dr. Teresa Hillier of Kaiser Permanente’s Center for Health Research in Portland, Ore.

That higher risk disappeared, however, when women with diabetes followed a special diet, exercised or were given insulin. Their children had about the same risk of becoming obese as those whose mothers had normal blood sugar, the researchers found.

“The important message is that the risk of child obesity related to gestational diabetes is potentially reversible,” said Hillier, adding that high blood sugar during pregnancy is contributing to the nation’s epidemic of childhood obesity.

The research, funded by the American Diabetes Association, is in the September issue of the group’s journal, Diabetes Care.

Gestational diabetes begins during pregnancy and usually goes away after childbirth. It affects 3 percent to 8 percent of pregnant women in the U.S. The mother’s elevated blood sugar can cause the fetus to grow too large, sometimes requiring delivery by cesarean section, and can bring on other health problems for the mother and baby.

Whether a mother’s high blood sugar can lead to childhood obesity has been less clear. It was seen in a study of Pima Indians and in some studies of other populations, the researchers said.

Dr. Boyd Metzger of Northwestern University said the Kaiser research complements a study he presented earlier this summer that suggests lowering the threshold for a diabetes diagnosis. His study found the higher the mother’s blood sugar, the greater the risk of complications for the newborn, even at levels below the cutoff for diabetes.

The new study, Metzger said, “just provides further evidence that we should be making changes in the diagnosis.”

RevContent Feed

More in News